Therefore, additional investigations are warranted to determine whether a regulatory response to gluten exists and whether an altered mucosal suppressive CD4+ T cell response to gluten contributes to CeD pathogenesis. The gene discussed is CD4; the disease is cranioectodermal dysplasia.